Detalles de la búsqueda
1.
Genome-Wide CRISPR Screen Identifies an NF2-Adherens Junction Mechanistic Dependency for Cardiac Lineage.
Circulation
; 149(25): 1960-1979, 2024 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38752370
2.
Efficacy and safety of Vibegron for the treatment of residual overactive bladder symptoms after laser vaporization of the prostate: A single-center prospective randomized controlled trial (VAPOR TRIAL).
Low Urin Tract Symptoms
; 16(4): e12529, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38956950
3.
Cutaneous and Renal Toxicities of Enfortumab Vedotin for Advanced Urothelial Carcinoma: The UROKYU Study.
Anticancer Res
; 44(7): 3025-3032, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38925809
4.
Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective Study.
Curr Oncol
; 31(2): 862-871, 2024 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38392058
5.
Interaction between docetaxel resistance and castration resistance in prostate cancer: implications of Twist1, YB-1, and androgen receptor.
Prostate
; 73(12): 1336-44, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23775496
6.
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study.
Anticancer Res
; 43(10): 4701-4708, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37772560
7.
Antioxidant therapy alleviates oxidative stress by androgen deprivation and prevents conversion from androgen dependent to castration resistant prostate cancer.
J Urol
; 187(2): 707-14, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22177207
8.
A prospective, single-center, randomized clinical trial to evaluate the efficacy of three types of laser vaporization surgeries using a 180-W GreenLight XPS laser, a 300-W diode laser, and a 200-W thulium laser for the treatment of benign prostatic hyperplasia.
Low Urin Tract Symptoms
; 14(5): 373-379, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-35719056
9.
Association Between Immune-Related Adverse Events and Efficacy and Changes in the Relative Eosinophil Count Among Patients with Advanced Urothelial Carcinoma Treated by Pembrolizumab.
Cancer Manag Res
; 14: 1641-1651, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35535266
10.
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
Clin Genitourin Cancer
; 20(5): 499.e1-499.e8, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35624001
11.
The Eosinophil Changes, Efficacy and Safety of Pembrolizumab in Advanced Urothelial Carcinoma Patients with an Older Age and a Poor Performance Status.
Onco Targets Ther
; 15: 1321-1330, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36388155
12.
Mitochondrial p32/C1QBP is highly expressed in prostate cancer and is associated with shorter prostate-specific antigen relapse time after radical prostatectomy.
Cancer Sci
; 102(3): 639-47, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21205079
13.
The significance of strong histone deacetylase 1 expression in the progression of prostate cancer.
Histopathology
; 58(5): 773-80, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21438903
14.
Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin.
BJU Int
; 107(7): 1148-53, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-20726978
15.
Twist1 and Y-box-binding protein-1 promote malignant potential in bladder cancer cells.
BJU Int
; 108(2 Pt 2): E142-9, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21083641
16.
Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based Chemotherapy.
In Vivo
; 35(5): 2869-2874, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34410980
17.
The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab.
Cancer Manag Res
; 13: 8049-8056, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729023
18.
Organ-Specific Tumor Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-Based Chemotherapy.
Onco Targets Ther
; 14: 1981-1988, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33776447
19.
Transformation of hard pollen into soft matter.
Nat Commun
; 11(1): 1449, 2020 03 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-32193375
20.
The Expression of Ubiquitous Mitochondrial Creatine Kinase Is Downregulated as Prostate Cancer Progression.
J Cancer
; 7(1): 50-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26722360